Hypoxia Induces Escape from Innate Immunity in Cancer Cells via Increased Expression of ADAM10: Role of Nitric Oxide

Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion

Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474 · see citing works

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.

Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212 · see citing works

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

Groh, V., Wu, J. D., Yee, C., & Spies, T. A. (2002) · Nature · doi:10.1038/nature01112 · Cited by 1,596 · see citing works

Hypoxia-Inducible Factor 1 (HIF-1) Pathway

Semenza, G. L. (2007) · Science s STKE · doi:10.1126/stke.4072007cm8 · Cited by 942 · see citing works

Redistribution of Intracellular Oxygen in Hypoxia by Nitric Oxide: Effect on HIF1α

Hagen, T., Taylor, C. T., Lam, F., & Moncada, S. (2003) · Science · doi:10.1126/science.1088805 · Cited by 704 · see citing works

Hypoxia and drug resistance

Teicher, B. A. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00689633 · Cited by 563 · see citing works

Untitled work

(1997) · PubMed · Cited by 433 · see citing works

Hypoxia-driven selection of the metastatic phenotype

Sullivan, R., & Graham, C. H. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9062-2 · Cited by 411 · see citing works

Tumor-Associated MICA Is Shed by ADAM Proteases

Waldhauer, I., Goehlsdorf, D., Gieseke, F., Weinschenk, T., Wittenbrink, M., Ludwig, A., Stevanović, S., Rammensee, H., & Steinle, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6768 · Cited by 376 · see citing works

Prevalent expression of the immunostimulatory MHC class I chain–related molecule is counteracted by shedding in prostate cancer

Wu, J. D., Higgins, L. M., Steinle, A., Cosman, D. J., Haugk, K. H., & Plymate, S. R. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22206 · Cited by 331 · see citing works

Evasion from NK Cell Immunity by MHC Class I Chain-Related Molecules Expressing Colon Adenocarcinoma

Doubrovina, E. S., Doubrovin, M., Vider, J., Sisson, R. B., O’Reilly, R. J., Dupont, B., & Vyas, Y. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6891 · Cited by 325 · see citing works

Soluble MICA in malignant diseases

Holdenrieder, S., Stieber, P., Peterfi, A., Nagel, D., Steinle, A., & Salih, H. R. (2005) · International Journal of Cancer · doi:10.1002/ijc.21382 · Cited by 241 · see citing works

Systemic NKG2D Down-Regulation Impairs NK and CD8 T Cell Responses In Vivo

Wiemann, K., Mittrücker, H., Feger, U., Welte, S. A., Yokoyama, W. M., Spies, T. A., Rammensee, H., & Steinle, A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.720 · Cited by 240 · see citing works

Inhibition of hypoxia-inducible factor 1 activity by nitric oxide donors in hypoxia

Sogawa, K., Numayama-Tsuruta, K., Ema, M., Abe, M., Abe, H., & Fujii-Kuriyama, Y. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7368 · Cited by 224 · see citing works

Hypoxia Potentiates Glioma-Mediated Immunosuppression

Wei, J., Wu, A., Kong, L. Y., Wang, Y., Fuller, G. N., Fokt, I., Melillo, G., Priebe, W., & Heimberger, A. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016195 · Cited by 220 · see citing works

Immunobiology of Human NKG2D and Its Ligands

Gonzalez, S. R., Groh, V., & Spies, T. A. (2005) · Current topics in microbiology and immunology · doi:10.1007/3-540-27743-9_6 · Cited by 211 · see citing works

The Cooperative Induction of Hypoxia-Inducible Factor-1α and STAT3 during Hypoxia Induced an Impairment of Tumor Susceptibility to CTL-Mediated Cell Lysis

Noman, M. Z., Buart, S., Van Pelt, J., Richon, C., Hasmim, M., Leleu, N., Suchorska, W. M., Jalil, A., Lecluse, Y., El Hage, F., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0800854 · Cited by 183 · see citing works

Nitric Oxide-Mediated Regulation of Chemosensitivity in Cancer Cells

Matthews, N. E., Adams, M. A., Maxwell, L., Gofton, T. E., & Graham, C. H. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.24.1879 · Cited by 167 · see citing works

Exposure to hypoxia, glucose starvation and acidosis: effect on invasive capacity of murine tumor cells and correlation with cathepsin (L + B) secretion

Cuvier, C., Jang, A., & Hill, R. P. (1997) · Clinical & Experimental Metastasis · doi:10.1023/a:1018428105463 · Cited by 156 · see citing works

Sorafenib inhibits the shedding of major histocompatibility complex class I–related chain A on hepatocellular carcinoma cells by down‐regulating a disintegrin and metalloproteinase 9†

Kohga, K., Takehara, T., Tatsumi, T., Ishida, H., Miyagi, T., Hosui, A., & Hayashi, N. (2009) · Hepatology · doi:10.1002/hep.23456 · Cited by 146 · see citing works

Hypoxia Increases Tumor Cell Shedding of MHC Class I Chain-Related Molecule: Role of Nitric Oxide

Siemens, D. R., Hu, N., Sheikhi, A., Chung, E., Frederiksen, L. J., Pross, H. F., & Graham, C. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0054 · Cited by 138 · see citing works

Chemosensitization of Cancer In vitro and In vivo by Nitric Oxide Signaling

Frederiksen, L. J., Sullivan, R., Maxwell, L., Macdonald-Goodfellow, S. K., ADAMS, M. A., Bennett, B. M., Siemens, D. R., & Graham, C. H. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1807 · Cited by 134 · see citing works

Cutting Edge: The Membrane Type Matrix Metalloproteinase MMP14 Mediates Constitutive Shedding of MHC Class I Chain-Related Molecule A Independent of A Disintegrin and Metalloproteinases

Liu, G., Atteridge, C. L., Wang, X., Lundgren, A. D., & Wu, J. D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903789 · Cited by 131 · see citing works

Hypoxia‐induced resistance to doxorubicin and methotrexate in human melanoma cell lines in vitro

Sanna, K., & Rofstad, E. K. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580219 · Cited by 85 · see citing works

Natural killer‐cell activity under conditions reflective of tumor micro‐environment

Loeffler, D. A., Heppner, G. H., & Juneau, P. L. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910480617 · Cited by 73 · see citing works

Nitric oxide‐mediated regulation of hypoxia‐induced B16F10 melanoma metastasis

Postovit, L.-M. M., ADAMS, M. A., Lash, G. E., Heaton, J. P. W., & Graham, C. H. (2003) · International Journal of Cancer · doi:10.1002/ijc.11556 · Cited by 60 · see citing works

Natural Killer Cell‐Mediated Basal and Interferon‐Enhanced Cytotoxicity against Liver Cancer Cells is Significantly Impaired Under In Vivo Oxygen Conditions

Fink, T., Ebbesen, P., Koppelhus, U., & Zachar, V. (2003) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2003.01347.x · Cited by 60 · see citing works

Adenosine inhibits activation‐induced T cell expression of CD2 and CD28 co‐stimulatory molecules: Role of interleukin‐2 and cyclic AMP signaling pathways

Butler, J. J., Mader, J. S., Watson, C. L., Zhang, H., Blay, J., & Hoskin, D. W. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10562 · Cited by 60 · see citing works

The effect of hypoxia on acquired drug resistance and response to epidermal growth factor in chinese hamster lung fibroblasts and human breast‐cancer cells in vitro

Kalra, R., Jones, A., Kirk, J., ADAMS, G. E., & Stratford, I. J. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540421 · Cited by 41 · see citing works

Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications

Lin, Y., Xu, J., & Lan, H. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0760-3 · Cited by 1,398 · see citing works

Hypoxic control of metastasis

Rankin, E. B., & Giaccia, A. J. (2016) · Science · doi:10.1126/science.aaf4405 · Cited by 1,340 · see citing works

Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy

Henke, E., Nandigama, R., & Ergün, S. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00160 · Cited by 1,142 · see citing works

A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells

Barsoum, I. B., Smallwood, C. A., Siemens, D. R., & Graham, C. H. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-0992 · Cited by 767 · see citing works

The role of HIF in immunity and inflammation

McGettrick, A. F., & O’Neill, L. A. J. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.08.002 · Cited by 768 · see citing works

The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment

Emami Nejad, A., Najafgholian, S., Rostami, A., Sistani, A., Shojaeifar, S., Esparvarinha, M., Nedaeinia, R., Haghjooy Javanmard, S., Taherian, M., Ahmadlou, M., et al. (2021) · Cancer Cell International · doi:10.1186/s12935-020-01719-5 · Cited by 693 · see citing works

Circulating and disseminated tumour cells — mechanisms of immune surveillance and escape

Mohme, M., Riethdorf, S., & Pantel, K. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.144 · Cited by 603 · see citing works

Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect

Rodriguez-Ruiz, M. E., Vanpouille‐Box, C., Melero, I., Formenti, S. C., & Demaria, S. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.06.001 · Cited by 502 · see citing works

Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia

Noman, M. Z., Hasmim, M., Messai, Y., Terry, S., Kiéda, C., Janji, B., & Chouaı̈b, S. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00207.2015 · Cited by 405 · see citing works

Fighting Immune Cold and Reprogramming Immunosuppressive Tumor Microenvironment with Red Blood Cell Membrane-Camouflaged Nanobullets

Yang, Z., Gao, D., Guo, X., Jin, L., Zheng, J., Wang, Y., Chen, S., Zheng, X., Zeng, L., Guo, M., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c07721 · Cited by 276 · see citing works

The role of hypoxia‐inducible factor 1 in tumor immune evasion

Li, Y., Wu, W., Wang, X., Fang, L., Adam, V., Nepovimová, E., Wu, Q., & Kuča, K. (2020) · Medicinal Research Reviews · doi:10.1002/med.21771 · Cited by 273 · see citing works

NKG2D and Its Ligands: “One for All, All for One”

Zingoni, A., Molfetta, R., Fionda, C., Soriani, A., Paolini, R., Cippitelli, M., Cerboni, C., & Santoni, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00476 · Cited by 255 · see citing works

Hypoxia and acidosis: immune suppressors and therapeutic targets

Damgaci, S., Ibrahim‐Hashim, A., Enríquez‐Navas, P. M., Pilon‐Thomas, S., Güveniş, A., & Gillies, R. J. (2018) · Immunology · doi:10.1111/imm.12917 · Cited by 230 · see citing works

Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy

Gupta, S., Roy, A., & Dwarakanath, B. S. R. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00068 · Cited by 218 · see citing works

Hypoxia Induced Impairment of NK Cell Cytotoxicity against Multiple Myeloma Can Be Overcome by IL-2 Activation of the NK Cells

Sarkar, S., Germeraad, W. T. V., Rouschop, K. M. A., Steeghs, E. M. P., van Gelder, M., Bos, G. M. J., & Wieten, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064835 · Cited by 215 · see citing works

Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges

Noman, M. Z., Hasmim, M., Lequeux, A., Xiao, M., Duhem, C., Chouaı̈b, S., Berchem, G., & Janji, B. (2019) · Cells · doi:10.3390/cells8091083 · Cited by 215 · see citing works

Immune-suppressive properties of the tumor microenvironment

Becker, J. C., Andersen, M. H., Schrama, D., & Straten, P. T. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1434-6 · Cited by 205 · see citing works

Mechanisms of Hypoxia-Mediated Immune Escape in Cancer

Barsoum, I. B., Koti, M., Siemens, D. R., & Graham, C. H. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-2598 · Cited by 202 · see citing works

The Critical Role of the Tumor Microenvironment in Shaping Natural Killer Cell-Mediated Anti-Tumor Immunity

Bagińska, J., Viry, E., Paggetti, J., Medves, S., Berchem, G., Moussay, E., & Janji, B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00490 · Cited by 196 · see citing works

Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977/miR-153 axis

Ou, Z., Luo, Z., Wei, W., Liang, S., Gao, T.-L., & Lu, Y. (2019) · RNA Biology · doi:10.1080/15476286.2019.1649585 · Cited by 172 · see citing works

Altered cancer metabolism in mechanisms of immunotherapy resistance

Ramapriyan, R., Caetano, M. S., Barsoumian, H. B., Mafra, A. C. P., Zambalde, É. P., Menon, H., Tsouko, E., Welsh, J. W., & Cortez, M. A. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.004 · Cited by 171 · see citing works

Arginine and the metabolic regulation of nitric oxide synthesis in cancer

Keshet, R., & Erez, A. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.033332 · Cited by 159 · see citing works

A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model

Oh, K., Lee, O.-Y., Shon, S.-Y., Nam, O., Ryu, P., Seo, M., & Lee, D.-S. (2013) · Breast Cancer Research · doi:10.1186/bcr3473 · Cited by 145 · see citing works

Efficiency and Target Derepression of Anti-miR-92a: Results of a First in Human Study

Abplanalp, W. T., Fischer, A., John, D., Zeiher, A. M., Gosgnach, W., Darville, H., Montgomery, R. L., Pestano, L. A., Allée, G., Paty, I., et al. (2020) · Nucleic Acid Therapeutics · doi:10.1089/nat.2020.0871 · Cited by 155 · see citing works

Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction

McDonald, P. C., Chafe, S. C., & Dedhar, S. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00027 · Cited by 151 · see citing works

Immune Response Regulation in the Tumor Microenvironment by Hypoxia

Labiano, S., Palazón, A., & Melero, I. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.02.009 · Cited by 151 · see citing works

Circadian rhythms and cancers: the intrinsic links and therapeutic potentials

Zhou, L., Zhang, Z., Nice, E. C., Huang, C., Zhang, W., & Tang, Y. C. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01238-y · Cited by 156 · see citing works

Hypoxia: a Double-Edged Sword in Cancer Therapy

Manoochehri Khoshinani, H., Afshar, S., & Najafi, R. (2016) · Cancer Investigation · doi:10.1080/07357907.2016.1245317 · Cited by 147 · see citing works

Recent Findings in the Regulation of Programmed Death Ligand 1 Expression

Shen, X., Zhang, L., Li, J., Li, Y., Wang, Y., & Xu, Z. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01337 · Cited by 131 · see citing works

Tumour Hypoxia-Mediated Immunosuppression: Mechanisms and Therapeutic Approaches to Improve Cancer Immunotherapy

Fu, Z., Mowday, A. M., Smaill, J. B., Hermans, I. F., & Patterson, A. V. (2021) · Cells · doi:10.3390/cells10051006 · Cited by 129 · see citing works

Circulating tumor cells in cancer patients: developments and clinical applications for immunotherapy

Zhong, X., Zhang, H.-T., Zhu, Y., Liang, Y., Yuan, Z., Li, J., Li, X., Li, X., Jia, Y., Tian, H., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-1141-9 · Cited by 128 · see citing works

The HIF target MAFF promotes tumor invasion and metastasis through IL11 and STAT3 signaling

Moon, E. J., Mello, S. S., Li, C. G., Chi, J., Thakkar, K. N., Kirkland, J. G., LaGory, E. L., Lee, I. J., Diep, A. N., Miao, Y. R., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24631-6 · Cited by 128 · see citing works

Current developments in nanotechnology for improved cancer treatment, focusing on tumor hypoxia

Phung, C. D., Tran, T. H., Pham, L. M., Nguyen, H. T., Jeong, J., Yong, C. S., & Kim, J. O. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.05.029 · Cited by 115 · see citing works

Intranasal Lactoferrin Enhances α-Secretase-Dependent Amyloid Precursor Protein Processing via the ERK1/2-CREB and HIF-1α Pathways in an Alzheimer’s Disease Mouse Model

Guo, C., Yang, Z., Zhang, S., Chai, R., Han, X., Zhang, Y., Li, J., & Wang, Z. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.8 · Cited by 111 · see citing works

Hypoxic Stress-Induced Tumor and Immune Plasticity, Suppression, and Impact on Tumor Heterogeneity

Terry, S., Buart, S., & Chouaı̈b, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01625 · Cited by 111 · see citing works

Fractalkine/CX3CL1 in Neoplastic Processes

Korbecki, J., Simińska, D., Kojder, K., Grochans, S., Gutowska, I., Chlubek, D., & Baranowska‐Bosiacka, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103723 · Cited by 110 · see citing works

Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma

Eckert, A. W., Wickenhauser, C., Salins, P. C., Kappler, M., Bukur, J., & Seliger, B. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0828-6 · Cited by 108 · see citing works

The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?

Jurj, A. M., Ionescu, C., Berindan‐Neagoe, I., & Braicu, C. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02484-1 · Cited by 109 · see citing works

Hypoxia-Induced Resistance to Chemotherapy in Cancer

Minassian, L. M., Cotechini, T., Huitema, E., & Graham, C. H. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12734-3_9 · Cited by 99 · see citing works

The Role of Circulating Tumor Cells in the Metastatic Cascade: Biology, Technical Challenges, and Clinical Relevance

Dianat‐Moghadam, H., Azizi, M., Eslami‐S, Z., Cortés‐Hernández, L. E., Heidarifard, M., Nouri, M., & Alix‐Panabières, C. (2020) · Cancers · doi:10.3390/cancers12040867 · Cited by 97 · see citing works

MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape

Codó, P., Weller, M., Meister, G., Szabó, E., Steinle, A., Wolter, M., Reifenberger, G., & Roth, P. (2014) · Oncotarget · doi:10.18632/oncotarget.2287 · Cited by 95 · see citing works

Immunometabolic Dysfunction of Natural Killer Cells Mediated by the Hypoxia-CD73 Axis in Solid Tumors

Chambers, A. M., & Matosevic, S. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00060 · Cited by 95 · see citing works

Overcoming tumor resistance mechanisms in CAR-NK cell therapy

Valeri, A., García-Ortiz, A., Castellano, E., Córdoba, L., Maroto-Martín, E., Encinas, J., Leivas, A., Rı́o, P., & Martínez‐López, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.953849 · Cited by 94 · see citing works

Emerging roles of miR-210 and other non-coding RNAs in the hypoxic response

Huang, X., & Zuo, J. (2014) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt141 · Cited by 89 · see citing works

Secretory pathways generating immunosuppressive NKG2D ligands: New targets for therapeutic intervention

Raneros, A. B., Álvarez, B. S., & López‐Larrea, C. (2014) · OncoImmunology · doi:10.4161/onci.28497 · Cited by 88 · see citing works

Melatonin stimulates the nonamyloidogenic processing of β APP through the positive transcriptional regulation of ADAM10 and ADAM17

Shukla, M., Htoo, H. H., Wintachai, P., Hernandez, J., Dubois, C. M., Postina, R., Xu, H., Checler, F., Smith, D. R., Govitrapong, P., et al. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12200 · Cited by 88 · see citing works

Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours

Shenouda, M. M., Gillgrass, A. E., Nham, T., Hogg, R. T., Lee, A. J., Chew, M. V., Shafaei, M., Aarts, C. W., Lee, D. A., Hassell, J. A., et al. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0867-9 · Cited by 80 · see citing works

Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future

Lamb, M. G., Rangarajan, H. G., Tullius, B. P., & Lee, D. A. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02277-x · Cited by 79 · see citing works

Tumor Microenvironment-Induced Immunometabolic Reprogramming of Natural Killer Cells

Chambers, A. M., Lupo, K. B., & Matosevic, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02517 · Cited by 75 · see citing works

Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?

Yuan, C.-S., Deng, Z., Qin, D., Mu, Y., Chen, X., & Liu, Y. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.02.030 · Cited by 71 · see citing works

NKG2D Ligand Shedding in Response to Stress: Role of ADAM10

Zingoni, A., Vulpis, E., Loconte, L., & Santoni, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00447 · Cited by 66 · see citing works

Hypoxia induces immunosuppression, metastasis and drug resistance in pancreatic cancers

Zhang, H., Cao, K., Xiang, J., Zhang, M., Zhu, M., & Xi, Q. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216345 · Cited by 67 · see citing works

Combining Antiangiogenic Therapy with Adoptive Cell Immunotherapy Exerts Better Antitumor Effects in Non-Small Cell Lung Cancer Models

Shi, S., Wang, R., Chen, Y., Song, H., Chen, L., & Huang, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065757 · Cited by 66 · see citing works

Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation

Fionda, C., Abruzzese, M. P., Zingoni, A., Soriani, A., Ricci, B., Molfetta, R., Paolini, R., Santoni, A., & Cippitelli, M. (2015) · BMC Cancer · doi:10.1186/s12885-015-1023-5 · Cited by 65 · see citing works

Gain of HIF-1α under Normoxia in Cancer Mediates Immune Adaptation through the AKT/ERK and VEGFA Axes

Lee, Y.-H., Bae, H. C., Noh, K. H., Song, K.-H., Ye, S.-K., Mao, C.-P., Lee, K.-M., Wu, T.-C., & Kim, T. W. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1979 · Cited by 64 · see citing works

Association of PD-L1 and HIF-1α Coexpression with Poor Prognosis in Hepatocellular Carcinoma

Dai, X., Pi, G., Yang, S., Chen, G. Y., Liu, L., & Dong, H. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.02.014 · Cited by 63 · see citing works

Hypoxia-inducible factors as key regulators of tumor inflammation

Mamlouk, S., & Wielockx, B. (2013) · International Journal of Cancer · doi:10.1002/ijc.27901 · Cited by 61 · see citing works

Hypoxia downregulates the expression of cell surface MICA without increasing soluble MICA in osteosarcoma cells in a HIF-1α-dependent manner

Yamada, N., Yamanegi, K., Ohyama, H., Hata, M., Nakasho, K., Futani, H., Okamura, H., & Terada, N. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1630 · Cited by 62 · see citing works

Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors

Eckert, F., Zwirner, K., Boeke, S., Thorwarth, D., Zips, D., & Huber, S. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00407 · Cited by 60 · see citing works

Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactions

Kravchenko, J. S., Corsini, E., Williams, M. A., Decker, W. K., Manjili, M. H., Otsuki, T., Singh, N., Al‐Mulla, F., Al-Temaimi, R. A., Amedei, A., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv033 · Cited by 60 · see citing works

Signal Propagation in Protein Interaction Network during Colorectal Cancer Progression

Jiang, Y., Huang, T., Chen, L., Gao, Y., Cai, Y., & Chou, K. (2013) · BioMed Research International · doi:10.1155/2013/287019 · Cited by 58 · see citing works

Cancer Cell Metabolism Bolsters Immunotherapy Resistance by Promoting an Immunosuppressive Tumor Microenvironment

Jiang, Z., Hsu, J. L., Li, Y., Hortobágyi, G. N., & Hung, M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01197 · Cited by 60 · see citing works

Repurposing Drugs in Oncology (ReDO)—nitroglycerin as an anti-cancer agent

Sukhatme, V. V., Bouche, G., Meheus, L., Sukhatme, V. P., & Pantziarka, P. (2015) · ecancermedicalscience · doi:10.3332/ecancer.2015.568 · Cited by 56 · see citing works

Tuning cancer fate: the unremitting role of host immunity

Calì, B., Molon, B., & Viola, A. (2017) · Open Biology · doi:10.1098/rsob.170006 · Cited by 55 · see citing works

Radiotherapy in Combination With Cytokine Treatment

Palata, O., Podzimkova, N., Nedvedova, E., Umprecht, A., Sadilkova, L. K., Jelinkova, L. P., Špíšek, R., & Adkins, I. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00367 · Cited by 51 · see citing works

Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy

Khouzam, R. A., Janji, B., Thiery, J., Zaarour, R. F., Chamseddine, A. N., Mayr, H., Savagner, P., Kiéda, C., Gad, S., Buart, S., et al. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.11.008 · Cited by 51 · see citing works

Systems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and “swarm intelligence”

Tarabichi, M., Antoniou, A., Saiselet, M., Pita, J. M. G., Andry, G., Dumont, J. E., Detours, V., & Maenhaut, C. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9431-y · Cited by 50 · see citing works

An Eight-Gene Hypoxia Signature Predicts Survival in Pancreatic Cancer and Is Associated With an Immunosuppressed Tumor Microenvironment

Khouzam, R. A., Rao, R. S. P., Venkatesh, G. H., Zeinelabdin, N. A., Buart, S., Meylan, M., Nimmakayalu, M. A., Terry, S., & Chouaı̈b, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.680435 · Cited by 48 · see citing works

The Effect of Disintegrin–Metalloproteinase ADAM9 in Gastric Cancer Progression

Kim, J., Jeung, H., Rha, S. Y., Yu, E., Kim, T. S., Shin, Y. K., Zhang, X., Park, K.-H., Park, S. W., Chung, H. C., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-1001 · Cited by 48 · see citing works

Natural Killer Cell-Based Immunotherapy against Glioblastoma

Morimoto, T., Nakazawa, T., Maeoka, R., Nakagawa, I., Tsujimura, T., & Matsuda, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032111 · Cited by 48 · see citing works

NF-κB and TET2 promote macrophage reprogramming in hypoxia that overrides the immunosuppressive effects of the tumor microenvironment

de la Calle‐Fabregat, C., Calafell-Segura, J., Gardet, M., Dunsmore, G., Mulder, K., Ciudad, L., Silvin, A., Moreno‐Càceres, J., Corbí, A. L., Muñoz‐Pinedo, C., et al. (2024) · Science Advances · doi:10.1126/sciadv.adq5226 · Cited by 47 · see citing works

Tumor Necrosis Factor Alpha-Induced Hypoxia-Inducible Factor 1α–β-Catenin Axis Regulates Major Histocompatibility Complex Class I Gene Activation through Chromatin Remodeling

Ghosh, S., Paul, A., & Sen, E. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01254-12 · Cited by 47 · see citing works

Potential therapeutic applications of phosphodiesterase inhibition in prostate cancer

Hamilton, T. K., Hu, N., Kolomitro, K., Bell, E. N., Maurice, D. H., Graham, C. H., & Siemens, D. R. (2012) · World Journal of Urology · doi:10.1007/s00345-012-0848-7 · Cited by 47 · see citing works

The Reactive Species Interactome in the Brain

Malard, E., Valable, S., Bernaudin, M., Pérès, E. A., & Châtre, L. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8238 · Cited by 46 · see citing works

Sensors, Transmitters, and Targets in Mitochondrial Oxygen Shortage—A Hypoxia-Inducible Factor Relay Story

Dehne, N., & Brüne, B. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4776 · Cited by 44 · see citing works

Cell Death Conversion under Hypoxic Condition in Tumor Development and Therapy

Qiu, Y., Li, P., & Ji, C. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161025536 · Cited by 44 · see citing works

Regulation of the α-secretase ADAM10 at transcriptional, translational and post-translational levels

Vincent, B. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.03.020 · Cited by 45 · see citing works

ADAM10 Sheddase Activity is a Potential Lung-Cancer Biomarker

Yoneyama, T., Gorry, M. C., Sobo-Vujanovic, A., Lin, Y., Vujanovic, L. N., Gaither‐Davis, A., Moss, M. L., Miller, M. A., Griffith, L. G., Lauffenburger, D. A., et al. (2018) · Journal of Cancer · doi:10.7150/jca.24601 · Cited by 44 · see citing works

Disseminated tumour cells in bone marrow are the source of cancer relapse after therapy

Sai, B., & Xiang, J. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13867 · Cited by 42 · see citing works

The Impact of Obesity, Adipose Tissue, and Tumor Microenvironment on Macrophage Polarization and Metastasis

Habanjar, O., Diab‐Assaf, M., Caldefie‐Chezet, F., & Delort, L. (2022) · Biology · doi:10.3390/biology11020339 · Cited by 41 · see citing works

Novel role of immune-related non-coding RNAs as potential biomarkers regulating tumour immunoresponse via MICA/NKG2D pathway

Zhang, J., Luo, Q., Li, X., Guo, J., Zhu, Q. K., Lu, X., Wei, L., Xiang, Z., Peng, M., Ou, C., et al. (2023) · Biomarker Research · doi:10.1186/s40364-023-00530-4 · Cited by 38 · see citing works

Nitric Oxide and Immune Responses in Cancer: Searching for New Therapeutic Strategies

Sahebnasagh, A., Saghafi, F., Negintaji, S., Hu, T., Shabani-Borujeni, M., Safdari, M., Ghaleno, H. R., Miao, L., Qi, Y., Wang, M., et al. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210707194543 · Cited by 37 · see citing works

Harnessing Natural Killer Cells in Non-Small Cell Lung Cancer

Russell, É., Conroy, M. J., & Barr, M. P. (2022) · Cells · doi:10.3390/cells11040605 · Cited by 37 · see citing works

Functional Plasticity of Gamma Delta T Cells and Breast Tumor Targets in Hypoxia

Siegers, G. M., Dutta, I., Lai, R. L., & Postovit, L.-M. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01367 · Cited by 36 · see citing works

Circular RNA and tumor microenvironment

Song, H., Liu, Q., & Liao, Q. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01301-z · Cited by 36 · see citing works

β-defensin-3 negatively regulates TLR4–HMGB1 axis mediated HLA-G expression in IL-1β treated glioma cells

Gupta, P., Ghosh, S., Nagarajan, A., Mehta, V. S., & Sen, E. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.12.001 · Cited by 36 · see citing works

Histo-genomics: digital pathology at the forefront of precision medicine

Barsoum, I. B., Tawedrous, E., Faragalla, H., & Yousef, G. M. (2018) · Diagnosis · doi:10.1515/dx-2018-0064 · Cited by 35 · see citing works

A hypoxia-induced decrease of either MICA/B or Hsp70 on the membrane of tumor cells mediates immune escape from NK cells

Schilling, D., Tetzlaff, F., Konrad, S., Li, W., & Multhoff, G. (2014) · Cell Stress and Chaperones · doi:10.1007/s12192-014-0532-5 · Cited by 32 · see citing works

Obstructive Sleep Apnea Monocytes Exhibit High Levels of Vascular Endothelial Growth Factor Secretion, Augmenting Tumor Progression

Cubillos-Zapata, C., Hernández-Jiménez, E., Avendaño-Ortiz, J., Toledano, V., Varela-Serrano, A., Fernández-Navarro, I., Casitas, R., Carpio, C., Aguirre, L. A., García-Río, F., et al. (2018) · Mediators of Inflammation · doi:10.1155/2018/7373921 · Cited by 31 · see citing works

Post-translational Mechanisms Regulating NK Cell Activating Receptors and Their Ligands in Cancer: Potential Targets for Therapeutic Intervention

Molfetta, R., Zingoni, A., Santoni, A., & Paolini, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02557 · Cited by 31 · see citing works

Hypoxic tumor microenvironment: Destroyer of natural killer cell function

Zhang, Y., Guo, F., & Wang, Y. (2024) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2024.02.04 · Cited by 32 · see citing works

IL-15 enhances the anti-tumor activity of trastuzumab against breast cancer cells but causes fatal side effects in humanized tumor mice (HTM)

Wege, A. K., Weber, F., Kroemer, A., Ortmann, O., Nimmerjahn, F., & Brockhoff, G. (2016) · Oncotarget · doi:10.18632/oncotarget.13159 · Cited by 30 · see citing works

Hijacker of the Antitumor Immune Response: Autophagy Is Showing Its Worst Facet

Viry, E., Noman, M. Z., Arakelian, T., Lequeux, A., Chouaı̈b, S., Berchem, G., Moussay, E., Paggetti, J., & Janji, B. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00246 · Cited by 30 · see citing works

Breast Cancer Tumor Microenvironment and Molecular Aberrations Hijack Tumoricidal Immunity

Lin, H.-J. L., Liu, Y., Lofland, D., & Lin, J. (2022) · Cancers · doi:10.3390/cancers14020285 · Cited by 28 · see citing works

Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: The prime suspect in cancer therapeutic resistance

Aria, H., Rezaei, M., Nazem, S., Daraei, A., Nikfar, G., Mansoori, B., Bahmanyar, M., Tavassoli, A., Vakil, M. K., & Mansoori, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.947885 · Cited by 26 · see citing works

Tumor Immune Microenvironment in Gynecologic Cancers

Margul, D. J., Yu, C., & AlHilli, M. M. (2023) · Cancers · doi:10.3390/cancers15153849 · Cited by 24 · see citing works

Prostate cancer cells hyper-activate CXCR6 signaling by cleaving CXCL16 to overcome effect of docetaxel

Kapur, N., Mir, H., Sonpavde, G., Jain, S. R., Bae, S., Lillard, J. W., & Singh, S. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.04.001 · Cited by 25 · see citing works

The role of tumor-associated macrophages and soluble mediators in pulmonary metastatic melanoma

Xiong, K., Qi, M., Stoeger, T., Zhang, J., & Chen, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1000927 · Cited by 24 · see citing works

SEP enhanced the antitumor activity of 5-fluorouracil by up-regulating NKG2D/MICA and reversed immune suppression via inhibiting ROS and caspase-3 in mice

Ke, M., Wang, H., Zhou, Y., Li, J., Liu, Y., Zhang, M., Dou, J., Xi, T., Shen, B., & Zhou, C. (2016) · Oncotarget · doi:10.18632/oncotarget.10375 · Cited by 23 · see citing works

Carbonic Anhydrase IX in Tumor Tissue and Plasma of Breast Cancer Patients: Reliable Biomarker of Hypoxia and Prognosis

Režuchová, I., Bartošová, M., Belvončíková, P., Takáčová, M., Zaťovičová, M., Jelenska, L., Csáderová, L., Mečiarová, I., & Pohlodek, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054325 · Cited by 22 · see citing works

Abstract 4844: A novel mechanism of immune escape in cancer and its regulation by nitric oxide

Barsoum, I. B., Hamilton, T. K., Miles, E. A., Siemens, R. D., & Graham, C. H. (2012) · Cancer Research · doi:10.1158/1538-7445.am2012-4844

Mechanisms of hypoxia‐induced immune escape in cancer and their regulation by nitric oxide (85.1)

Graham, C. H., Barsoum, I. B., Kim, J. S., Black, M., Macdonald-Goodfellow, S. K., & Siemens, D. R. (2014) · The FASEB Journal · doi:10.1096/fasebj.28.1_supplement.85.1 · Cited by 1 · see citing works

Abstract 447: A mechanism of hypoxia-induced immune escape in cancer cells

Hamilton, T. K., Barsoum, I. B., Li, X., Miles, E. A., Elliott, J., Siemens, D. R., & Graham, C. H. (2011) · Cancer Research · doi:10.1158/1538-7445.am2011-447

Mechanisms Of Hypoxia-Induced Immune Escape In Cancer And Their Regulation By Nitric Oxide

Graham, C. H., Barsoum, I. B., Kim, J. S., Black, M., & Siemens, R. D. (2015) · Redox Biology · doi:10.1016/j.redox.2015.09.022 · Cited by 23 · see citing works

Nitric Oxide-Mediated Regulation of Cancer Immune Escape

Siemens, D. R., & Graham, C. H. (2010) · Forum on Immunopathological Diseases and Therapeutics · doi:10.1615/forumimmundisther.v1.i4.10